4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
tandardised questionnaires and the Global TB Drug Facility website.
more
guidance for health managers, health workers, and activists
Healthcare Waste Management Toolkit for Global Fund Practitioners and Policy Makers. Part B
A series of tools and templates have been developed by WHO, FAO and OIE to accompany the manual for developing national action plans on antimicrobial resistance
Health Systems in Transition. Vol. 5 No.3 2015
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But
...
despite such substantial progress, the country now faces new and emerging new challenges such as the rising burden of noncommunicable diseases, increased risks associated with disasters, environmental threats and health emergencies during disease outbreaks including the COVID-19 pandemic that is a serious public health threat to Bangladesh. To establish a resilience system for future potential pandemics, the national capacity for emergency preparedness and early response to health emergencies needs to be bolstered considerably.
more
NHSP 2017- 2022 (Final draft)
Towards ending tuberculosis and multidrug-resistant tuberculosis.
African Journal of Laboratory Medicine | Vol 7, No 2 | a770 | 06 December 2018